Quest Diagnostics (DGX) Minority Interest (2009 - 2026)

Quest Diagnostics has disclosed Minority Interest across 18 years of filings, most recently posting $303.0 million for Q2 2026.

• In Q2 2026, Minority Interest rose 274.07% year-over-year to $303.0 million; the TTM figure through Jun 2026 stood at $303.0 million (up 274.07% YoY), while the FY2025 annual figure was $80.0 million, down 3.61% from the prior year.
• Minority Interest came in at $303.0 million for Q2 2026 at Quest Diagnostics, up from $300.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $303.0 million in Q2 2026 to a low of $76.0 million in Q3 2023.
• Average Minority Interest over 5 years is $103.3 million, with a median of $78.5 million recorded in 2022.
• Year-over-year, Minority Interest slipped 3.61% in 2025 and soared 274.07% in 2026.
• Over 5 years, Minority Interest stood at $77.0 million in 2022, then slipped by 1.3% to $76.0 million in 2023, then rose by 9.21% to $83.0 million in 2024, then decreased by 3.61% to $80.0 million in 2025, then jumped by 278.75% to $303.0 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were $303.0 million in Q2 2026, $300.0 million in Q1 2026, and $80.0 million in Q4 2025.